Fitness6 months ago
First Oral PCSK9 Shows Promise Lowering Cholesterol
LYON, France — The first oral small molecule anti–proprotein convertase subtilisin kexin type 9 (PCSK9) inhibitor appears to be effective in not only lowering low-density lipoprotein...
